The Supreme Court on Tuesday pulled up hospitals for selling cancer drugs at a steep markup of ten times and asked the Centre to examine whether a uniform 16% margin should apply to all medicines.
The bench also questioned corporate hospitals that require patients to buy medicines only from their own chemists.
